Who to follow: HealthTech executives
MC
Marty Culjat, PhD
SVP of Digital Medicine and DTx · EVERSANA
Digital TherapeuticsNorth AmericaEstablished
Why follow Marty
Marty shares practical advice on how to commercialize digital therapeutics, navigate regulatory hurdles, and gain clinical adoption from providers.
Writes about
CommercializationMedical AffairsRegulatory Strategy
Best for
Regulatory affairs professionals and commercial teams